Home » Ortho Clinical Diagnostics Earns CE Mark Approval
Ortho Clinical Diagnostics Earns CE Mark Approval
Ortho Clinical Diagnostics has nabbed CE mark approval for its VITROS HIV combo test, the Raritan, N.J.-based company announced Tuesday.
The test is intended for the detection of both HIV-1 and HIV-2 antibodies and the p24 antigen.
The new addition expands the company’s existing infectious disease portfolio. — Anisa Jibrell
Upcoming Events
-
07May
-
14May
-
30May